IL1A and Alzheimer disease: This damage to DNA might contribute to abnormal epidermal barrier function and inflammation by increasing the activation of NF-κB and COX2 and by promoting the production of IL-6 and IL-1α in KCs [148,149,150], cellular abnormalities observed in the epidermis of patients with AD.